Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure

Partners/ AuthorsCatherine Klersy, Annalisa De Silvestri, Gabriella Gabutti, Arturo Raisaro, Moreno Curti, François Regoli, Angelo Auricchio
Start & end date2011
FocusTo assess the cost-effectiveness and the cost utility of remote patient monitoring (RPM) when compared with the usual care approach based upon differences in the number of hospitalizations, estimated from a meta-analysis of randomized clinical trials (RCTs).
OutcomeThe difference in costs between RPM and usual care ranged from €300 to €1000, favouring RPM. These cost savings combined with a quality-adjusted life years (QALYs) gain of 0.06 suggest that RPM is a 'dominant' technology over existing standard care.